Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children

被引:45
|
作者
Catt, Caroline J. [1 ,3 ,4 ,5 ]
Hamilton, Gavin M. [3 ]
Fish, Joel [2 ,3 ]
Mireskandari, Kamiar [1 ,3 ]
Ali, Asim [1 ,3 ]
机构
[1] Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Plast Surg, Burn Unit, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Childrens Hosp Westmead, Sydney, NSW, Australia
[5] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
关键词
ERYTHEMA MULTIFORME; COMPLICATIONS; MANAGEMENT;
D O I
10.1016/j.ajo.2016.03.020
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To describe the acute and chronic ocular manifestations of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN Overlap syndrome (Overlap syndrome) in children. DESIGN: Retrospective case series. METHODS: Medical records of children admitted to the Hospital for Sick Children between 2001 and 2011 with SJS, TEN, and Overlap syndrome were reviewed. Demographic information, all abnormal ophthalmic findings (and median time to first diagnosis), visual acuities, and ophthalmic treatments prescribed were collected for each eye for every patient. RESULTS: Thirty-six children were identified for inclusion in the study. Twenty-nine (81%) had acute ocular involvement, including all patients with TEN (n = 7). Conjunctivitis was the most common (78%) clinical sign. This, together with conjunctival membranes and subconjunctival hemorrhage, were the earliest signs, presenting by a median of 1 day. The percentage of patients and median time to occurrence of complications were as follows: for lid margin ulceration and corneal epithelial defects, 25%, 3 days; conjunctival ulceration, 39%, 3.5 days; symblepharon, 28%, 4 weeks; corneal opacification, 11%, 4 months; limbal stem cell failure, 8%, 7 months; and corneal vascularisation, 8%, 10 months after admission. Over 90% of children maintain a visual acuity of 20/40 or better in each eye at a mean follow-up of 1.4 years. CONCLUSIONS: Ocular involvement in SJS, TEN, and Overlap syndrome is common and the ocular manifestations may develop many months after the initial presentation, mandating the need for long-term follow-up of these children. Despite the high frequency of sight-threatening disease, most children maintain good vision in the long term. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 75
页数:8
相关论文
共 50 条
  • [21] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population A Review
    Alerhand, Stephen
    Cassella, Courtney
    Koyfman, Alex
    PEDIATRIC EMERGENCY CARE, 2016, 32 (07) : 472 - 476
  • [22] Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Saeed, Hajirah N.
    Chodosh, James
    SEMINARS IN OPHTHALMOLOGY, 2016, 31 (1-2) : 85 - 90
  • [23] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lerch, Marianne
    Mainetti, Carlo
    Beretta-Piccoli, Benedetta Terziroli
    Harr, Thomas
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (01) : 147 - 176
  • [24] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Evaluation
    Dicle, Oezlem
    Yilmaz, Ertan
    Alpsoy, Erkan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (01): : 15 - 20
  • [25] Diagnosis and management of Stevens-Johnson syndrome toxic epidermal necrolysis
    Noe, Megan H.
    Micheletti, Robert G.
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 607 - 612
  • [26] Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
    Shah, Hemali
    Parisi, Rose
    Mukherjee, Eric
    Phillips, Elizabeth J.
    Dodiuk-Gad, Roni P.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (06) : 891 - 908
  • [27] Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Chi, Min-Hui
    Chung, Wen-Hung
    Hui, Rosaline Chung-Yee
    Chen, Chun-Bing
    Lu, Chun-Wei
    Chiu, Tsu-Man
    Ma, David Hui-Kang
    Wang, Chuang-Wei
    Yang, Chin-Yi
    JOURNAL OF DERMATOLOGY, 2022, 49 (09) : 895 - 902
  • [28] Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Spectrum for the Rheumatologist
    Parida, Jyoti Ranjan
    Tripathy, Saumya Ranjan
    INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 : S67 - S75
  • [29] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Marianne Lerch
    Carlo Mainetti
    Benedetta Terziroli Beretta-Piccoli
    Thomas Harr
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 147 - 176
  • [30] Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Sato, Satoshi
    Kanbe, Tomoka
    Tamaki, Zenshiro
    Furuichi, Mihoko
    Uejima, Yoji
    Suganuma, Eisuke
    Takano, Tadamasa
    Kawano, Yutaka
    PEDIATRICS INTERNATIONAL, 2018, 60 (08) : 697 - 702